BSE filing, NSE: VIJAYA. Summary written from the filing by ALFA Finder's alert engine.
Vijaya Diagnostic Centre Ltd: key numbers
- Share price
- ₹1,442.80
- Market cap
- ₹14,861 Cr
- Revenue (annual)
- ₹814.2 Cr
- Net profit (annual)
- ₹173.0 Cr
- P/E (TTM)
- 79.3×Sector 52.0×
- Promoter holding
- 52.46%-0.05% QoQ
- FII holding
- 10.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vijaya Diagnostic Centre Ltd
All →Vijaya Diagnostic Centre Board Meeting Date
Vijaya Diagnostic Centre scheduled a board meeting for 3 Nov 2026 to approve unaudited Q1 and H1 FY27 results. No financial figures or material decisions are disclosed in this notice.
Vijaya Diagnostic Centre Other Announcement
Vijaya Diagnostic Centre Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This report details the share distribution among various shareholder categories.
Vijaya Diagnostic Centre Annual General Meeting
Vijaya Diagnostic Centre held its 24th Annual General Meeting on September 24, 2026. Shareholders transacted ordinary and special business, including declaring a final dividend.
Vijaya Diagnostic Centre Acquisition
Vijaya Diagnostic Centre is acquiring 100% of Arya Wellness Centre in Guwahati. The company published an investor presentation detailing the acquisition's strategic rationale and financial highlights.
Vijaya Diagnostic Centre Merger & Restructuring Worth ₹46.2 Cr
Vijaya Diagnostic Centre acquires the diagnostic business undertaking of Arya Wellness Centre for ₹46.20 Crore on a slump sale basis to expand its North-East India presence.
- Value
- ₹46.20 Cr
Vijaya Diagnostic Centre Acquisition Worth ₹46.2 Cr
Vijaya Diagnostic Centre Ltd acquired the integrated diagnostic business of Arya Wellness Centre for ₹46.20 Crore. This slump sale expands its presence into the North-East.
- Value
- ₹46.20 Cr
- From
- Arya Wellness Centre
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date